Margaret Koziel
Company: Axcella Therapeutics
Job title: Chief Medical Officer
Seminars:
Harnessing Endogenous Metabolic Modulators to Target Multiple Disease Pathways in NASH 3:00 pm
Monitoring disease progression and therapeutic efficacy with non-invasive biomarkers in clinical studies Reversing NASH through targeting multiple pathways Managing diverse patient populations and investigating clinical data: with and without type 2 diabetes and navigating pediatric studiesRead more
day: Day One
Panel Discussion: Obesity, Diabetes & NASH: What do Payers Need to See? 2:00 pm
Defining payer expectations and considering long term value Assessing higher risk patient populations and preventing comorbidities Harmonizing global patient metricsRead more
day: Day 1 Stream 2 PM